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Estimation of HIV Burden through
Bayesian Evidence Synthesis
Daniela De Angelis, Anne M. Presanis, Stefano Conti and A. E. Ades
Abstract. Planning, implementation and evaluation of public health
policies to control the human immunodeficiency virus (HIV) epidemic
require regular monitoring of disease burden. This includes the pro-
portion living with HIV, whether diagnosed or not, and the rate of
new infections in the general population and in specific risk groups
and regions. Estimation of these quantities is not straightforward: data
informing them directly are not typically available, but a wealth of in-
direct information from surveillance systems and ad hoc studies can
inform functions of these quantities. In this paper we show how the
estimation problem can be successfully solved through a Bayesian ev-
idence synthesis approach, relaxing the focus on “best available” data
to which classical methods are typically restricted. This more com-
prehensive and flexible use of evidence has led to the adoption of our
proposed approach as the official method to estimate HIV prevalence
in the United Kingdom since 2005.
Key words and phrases: Bayesian inference, evidence synthesis, graph-
ical model, HIV, disease burden.
1. INTRODUCTION
The HIV disease is associated with serious mor-
bidity, high costs of treatment and care, and, in
developing countries, with significant mortality and
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a high number of potential years of life lost (Joint
United Nations Programme on HIV/AIDS (2010)).
Planning for care provision and for implementation
and evaluation of public health policies to reduce
transmission relies crucially on robust monitoring
of disease burden. This burden includes the propor-
tion (prevalence) living with HIV; the proportion
of infections remaining undiagnosed; and the rate
at which new infections occur (incidence), in both
the general population and in specific groups at high
risk of infection and in different locations. To acquire
robust evidence on these quantities is not easy. The
assessment of HIV prevalence is complicated by the
absence of symptoms for a long time after infection.
Incidence is even more difficult to measure, requir-
ing, at least, longitudinal follow-up of uninfected in-
dividuals, with all the complications of cohort stud-
ies.
Devising appropriate methods for estimation of
prevalence and incidence has generated a rich liter-
ature in the last 30 years (Brookmeyer (2010), Pre-
sanis (2010)). For HIV prevalence “direct” methods
have been particularly popular amongst the medi-
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cal community (e.g., McGarrigle et al. (2006), Ly-
erla et al. (2006) and references therein) for their
apparent transparency. The underlying idea is that
the general population, of size N , is subdivided into
G nonoverlapping groups at different risk of acquir-
ing HIV. Estimates of proportions ρg of risk group
g (g = 1, . . . ,G) in the population are multiplied
by estimates of the prevalence pig of HIV to pro-
duce a point estimate of the number of infected
individuals Npigρg in each group and in the pop-
ulation N
∑
g ρgpig = N
∑
g(ρgpigδg + ρgpig(1− δg)).
Here δg denotes the proportion of infected individ-
uals diagnosed in group g, and N
∑
g ρgpigδg and
N
∑
g ρgpig(1 − δg) represent the number of diag-
nosed and undiagnosed infections in group g, re-
spectively. Typically, at least in developed countries
with concentrated epidemics like the United King-
dom (UK), the number of diagnosed infections is
known from surveillance schemes, so the problem is
to estimate the number of undiagnosed infections.
Provided direct data that measure size and preva-
lence for each group are available, these methods are
very simple and, consequently, appealing. However,
direct information on all parameters is not typically
available, whereas there is a wealth of indirect infor-
mation, from a variety of sources, which may inform
functions of the parameters of interest. This addi-
tional indirect information is generally discarded as
difficult to incorporate in this simplistic framework.
As a result, on one hand, unverifiable assumptions
and ad hoc adjustments are made to compensate for
the lack of information. On the other hand, an ineffi-
cient use is made of the information that is available,
with consequent imprecise and biased results due to
the selective nature of the data used in the estima-
tion. Finally, in the “direct” methods there is no
explicit model formulation, so it is not possible to
quantify formally the uncertainty surrounding the
resulting estimates or to validate them.
The statistical challenge is then to provide an in-
ferential approach capable of combining direct and
indirect information from multiple sources and ap-
propriately accounting for any uncertainty in the
data and parameters. The Bayesian paradigm nat-
urally offers the most appropriate framework to ad-
dress this challenge (see Section 5). Bayesian syn-
thesis of evidence from different studies, perhaps
even those with different designs, is not new (e.g.,
Eddy, Hasselblad and Shachter (1992), Dominici
et al. (1999), Ades and Sutton (2006)) and is at-
tracting increasing attention with applications in
various fields (e.g., Spiegelhalter and Best (2003),
Clark et al. (2010), Govan et al. (2010), Birrell et al.
(2011)).
In this paper, we describe how such an approach
has been successfully adopted to estimate HIV
prevalence and incidence in England and Wales
(E&W) in the population aged 15–44. The remain-
der of the paper is organised as follows: the con-
cept of Bayesian evidence synthesis is defined in
Section 2; the model to estimate HIV prevalence
is presented in Section 3; a joint model for preva-
lence and incidence is described in Section 4; and
Section 5 offers a concluding discussion.
2. BAYESIAN EVIDENCE SYNTHESIS
Let θ = (θ1, . . . , θK) represent the parameter vec-
tor we are interested in estimating. We refer to θ
as basic parameters. Denote by y = (y1, . . . ,yn) a
collection of n ≥ K independent data items avail-
able for the estimation of θ. Each yi provides either
direct information on a single component θk of θ
or indirect information, that is, on functional pa-
rameters, expressed in terms of one or more compo-
nent(s) of θ. Denote by ψi = ψi(θ) a generic func-
tion of θ, which may represent the identity function,
that is, ψi = θk, a function of a single parameter
ψi = ψi(θk) or a function of multiple components of
θ, ψi = ψi(θ). Indicating by Li(ψi(θ);yi) the like-
lihood contribution of yi to the basic parameter
vector θ, from the independence of the yi, the full
data likelihood is L(θ;y) =
∏n
i=1Li(ψi(θ);yi). From
a Bayesian perspective, expressing the prior knowl-
edge on θ through a prior distribution p(θ), infer-
ence is conducted on the basis of the posterior dis-
tribution p(θ | y) ∝ p(θ)L(θ;y), which summarises
all information, both direct and indirect, on θ. Such
a distribution fully reflects the uncertainty about
θ, including sampling variability and parameter un-
certainty, which automatically percolates through
to any function of the basic parameters θ. Fig-
ure 1 provides a direct acyclic graph (DAG) (Lau-
ritzen (1996)) representation of the generic formu-
lation above and shows schematically the depen-
dency between data and parameters as well as the
flow of information within the system. Here stochas-
tic “nodes” are represented by circles and observed
“nodes” by squares. The basic parameters, in dou-
ble circles, are given prior (possibly hierarchical) dis-
tributions. Solid arrows represent distributional as-
sumptions, and dashed arrows indicate functional
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Fig. 1. DAG representation of a generic evidence synthesis
model.
relationships. Note the examples of functional pa-
rameters that inform multiple components of θ, such
as ψi = ψi(θ1, θk). Information flows along the ar-
rows, from the prior and from the data. The pos-
terior distribution of each θk is based on its prior
distribution and on direct and indirect information
available on it, as well as the priors and information
on other components of θ.
3. HIV PREVALENCE ESTIMATION
Extending the notation introduced in Section 1,
HIV prevalence pit,r in the general population at a
single point in time t in location r may be expressed
as pit,r =
∑
g ρt,g,rpit,g,r =
∑
g ρt,g,rpit,g,rδt,g,r +∑
g ρt,g,r × pit,g,r(1 − δt,g,r). The aim is to estimate
the basic parameters θt,g,r = (ρt,g,r, pit,g,r, δt,g,r).
Having obtained the posterior distribution of these,
it is possible to obtain the posterior distribution of
any function of interest, for example, the total num-
ber of infections Nt,r
∑
g ρt,g,rpit,g,r or the total num-
ber of undiagnosed infections Nt,r
∑
g ρt,g,rpit,g,r(1−
δt,g,r), where Nt,r is the location- and time-specific
total population. There are 13 mutually exclusive
risk groups defining a hierarchy of risk. Men are
classified into the following: men who have sex with
men [MSM attending sexually transmitted infection
(STI) clinics; MSM not attending STI clinics; and
past MSM]; injecting drug users (IDU, current and
past); heterosexual men born in sub-Saharan Africa
(SSA); heterosexual men attending STI clinics; and
heterosexual men at low risk (LR) of infection. Het-
erosexual women are classified in the same way as
heterosexual men. Geographically, there are three
locations (Inner London, Outer London, Rest of
E&W), and t refers to the year 2008. In total there
are 11 × 3 + 13 × 3 + 13 × 3 = 111 parameters as∑
g ρt,g,r = 1 for each gender.
3.1 Data
Different types of data are available on the fol-
lowing: group sizes, HIV prevalence, prevalence of
undiagnosed infections, proportion of infections di-
agnosed, total number of diagnosed infections and
group distribution amongst diagnosed cases. Data
sources are described in full and commented upon
elsewhere (Goubar et al. (2008), Presanis et al.
(2010) and references therein), and are only briefly
reviewed here. Mid-year population estimates pro-
vide information on Nt,r and some risk group pro-
portions ρt,g,r. The remaining ρt,g,r are derived
from a behavioural survey. Unlinked anonymous
sero-prevalence surveys amongst STI clinic atten-
dees inform the prevalence of undiagnosed infec-
tion pit,g,r(1−δt,g,r). The analogous surveys amongst
pregnant women and IDUs inform prevalence pit,g,r
and proportion diagnosed δt,g,r, both directly for
some groups and indirectly through functions of
pit,g,r, δt,g,r and ρt,g,r. The pregnant women’s survey,
in particular, measures prevalence in those born in
SSA and the remainder (NSSA). These NSSA are
a mixture of STI clinic attendees, IDUs and lower
risk women. The observed data, therefore, provide
information on a complex function of HIV preva-
lence in these groups and account for the probabil-
ity of each group being included in the sample. An
annual cross-sectional survey of diagnosed individ-
uals collects information on functional parameters
representing both the total number living with di-
agnosed HIV (Nt,r
∑
g ρt,g,rpit,g,rδt,g,r) and the dis-
tribution of risk groups amongst these individu-
als ((ρt,g,rpit,g,rδt,g,r)/(
∑
g ρt,g,rpit,g,rδt,g,r)) for each
group g. Table 1 summarises the spread and the
type of information available as well as the relation-
ship between the available data and the basic pa-
rameters, expressed here through generic functions
ψ. Note the sparseness of information on heterosex-
ual men and the multiplicity of data on heterosexual
women.
3.2 Inference
Sampling distributions Information yt,g,r from
most sources can be expressed in the form of count
data xt,g,r with an associated denominator nt,g,r.
These data can be assumed to naturally be realisa-
tions of a binomial random variable
Xt,g,r ∼ binomial(nt,g,r, ψt,g,r),
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Table 1
Relationship between available data and parameters for a generic location r
Risk group N ρ pi δ ψ(ρ,pi) ψ(pi, δ) ψ(ρ,pi, δ)
Men MSM X X X
IDUs X X X X
Born sub-Saharan Africa X X
STI clinic attendees X X X
Lower risk
ALL X X
Women IDUs X X X X X
Born sub-Saharan Africa X X X X
STI clinic attendees X X X X
Lower risk X
ALL X X X
where ψt,g,r equals any of ρt,g,r, pit,g,r and δt,g,r if
yt,g,r provides direct information or is a function of
these basic parameters.
The observed total numbers of diagnosed men
and women in each location, xt,m,r and xt,f,r, re-
spectively, are assumed to be realisations of Pois-
son random variables Xt,m,r ∼ Poisson(µt,m,r) and
Xt,f,r ∼ Poisson(µt,f,r), where
µt,m,r =Nt,m,r
∑
gm
(1− νt,gm)δt,gm,rpit,gm,rρt,gm,r,
µt,f,r =Nt,f,r
∑
gf
(1− νt,gf )δt,gf ,rpit,gf ,rρt,gf ,r.
Here gm and gf refer to male and female groups,
respectively, and νt,gm, νt,gf are parameters repre-
senting potential bias in the reported number of
diagnosed individuals due to nonattendance, under-
reporting or duplication. The region-specific num-
bers diagnosed in each risk group, xt,gm,r and xt,gf ,r,
are simultaneously drawn from gender-specific multi-
nomial distributions with size parameters µt,m,r and
µt,f,r, and probability parameters
ξt,gm,r = ((1− νt,gm)δt,gm,rpit,gm,rρt,gm,r)/∑
gm
(1− νt,gm)δt,gm,rpit,gm,rρt,gm,r,
ξt,gf ,r = ((1− νt,gf )δt,gf ,rpit,gf ,rρt,gf ,r)/∑
gf
(1− νt,gf )δt,gf ,rpit,gf ,rρt,gf ,r.
The full likelihood Lt(θt;yt) results from the
product of each of these distributions, as generically
described in Section 2.
Sparseness of information One of the challenges
to the “direct” methods is the lack of informa-
tion on some risk groups. Table 1 clearly shows
that data on pit,g,r and δt,g,r for male heterosexu-
als are sparse. This sparsity can be addressed by
sharing information between men and women. Al-
though pit,g,r and δt,g,r are expected to vary by gen-
der and by location, it is reasonable to assume that
their male-to-female odds ratios might be similar be-
tween regions. To borrow strength across locations
and risk groups, the following hierarchical structures
are then assumed for the male-to-female log odds ra-
tios of prevalence lor.pit,g,r and proportion diagnosed
lor.δt,g,r:
logit(pit,gm,r) = lor.pit,g,r + logit(pit,gf ,r),
lor.pit,g,r ∼ normal(Pt,g, σ
2
t,pi),
logit(δt,gm,r) = lor.δt,g,r + logit(δt,gf ,r),
lor.δt,g,r ∼ normal(Dt,g, σ
2
t,δ),
with a further hierarchy over risk groups:
Pt,g ∼ normal(Πt, ω
2
t,pi), Dt,g ∼ normal(∆t, ω
2
t,δ).
The means Πt and ∆t are a priori distributed as
normal(0,1002). The standard deviations σt,pi, σt,δ
and ωt,δ are given informative priors expressing the
belief that only 5% of region-specific male-to-female
odds ratios (of both prevalence and proportion di-
agnosed) will vary from the mean by more than a
1.3 factor (Section 5.7.3 of Spiegelhalter, Abrams
and Myles (2004)). The odds ratios for prevalence
are assumed to vary more across risk groups than
across regions, hence, the prior for ωt,pi is weaker:
a factor of 1.6 is used.
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Fig. 2. Posterior median (95% credible interval) number of HIV infections in adults aged 15–44 in E&W in 2008, by
diagnosis status and risk group.
Bias modelling and other indirect information
A further challenge to the estimation problem is
represented by data that indirectly inform a specific
parameter of interest. The most common example
occurs where the data are known to be affected by
biases, as for the above total number of diagnosed
infections. The parameters νt,gm and νt,gf are, in this
case, introduced to model the known bias. In gen-
eral, this is dealt with by introducing “bias models”
that take the generic form θ′ = θ + ε on a suitable
scale, where θ is the parameter of interest and θ′ is
the parameter directly informed by the data. The
“bias parameter” ε is a measure of the discrepancy
between θ′ and θ. Where information or expert opin-
ion on the size and/or direction of the bias is avail-
able, this is expressed as an informative prior on ε.
Other challenges in the data sources, such as
greater spatial heterogeneity than is captured by the
regional structure adopted in the model, are met
by more complex modelling, such as mixed effects
regression on a finer regional stratification. The pa-
rameters ψt,g,r in the binomial expression above may
therefore have a more complex functional structure
than the examples given here; see Goubar et al.
(2008), Presanis et al. (2008), Presanis (2010) for
more details.
Priors Diffuse uniform priors are chosen for the
basic parameters pit,g,r and δt,g,r. The proportions of
the male and female populations in each risk group
ρt,gm,r and ρt,gf ,r are given Dirichlet priors such that
they sum to 1. Informative normal or uniform pri-
ors are assigned to bias parameters such as νt,gm
and νt,gf .
Results Samples from the posterior distribution
are obtained using Markov chain Monte Carlo
(MCMC), implemented in WinBUGS (Lunn et al.
(2000)). Posterior summaries are based on 8000
samples from two chains after convergence is achieved.
Figure 2 presents the estimated number of HIV in-
fections in E&W, by diagnosis status and risk group.
4. JOINT PREVALENCE AND INCIDENCE
MODEL
Application of the prevalence model over succes-
sive years using a sequence of data sets {yt}, t ∈
1, . . . , T , provides the joint posterior distribution
of the proportions of the population Nt,g,r in each
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Fig. 3. Schematic DAG of the joint prevalence and inci-
dence model.
of three compartments: susceptible to infection
st,g,r = ρt,g,r(1 − pit,g,r); HIV infected but undiag-
nosed ut,g,r = ρt,g,rpit,g,r(1− δt,g,r); and infected and
diagnosed dt,g,r = ρt,g,rpit,g,rδt,g,r. These can be in-
terpreted as estimates of the state at time t of a
dynamical system describing the processes of infec-
tion and diagnosis. Such a system can be approx-
imated by a continuous-time Markov model whose
dynamics are described through a system of ordi-
nary differential equations (ODEs). As in Presanis
et al. (2011), we focus here on the MSM group and,
for simplicity, drop the subscripts g and r. Let
ct = (st, ut, dt) and denote by λt the transition rates
in the time interval [t, t+1), assumed piecewise con-
stant over the interval. Using additional data {zt}
(Presanis et al. (2011)) and prior information on
demographics and risk behaviour uptake, a joint
prevalence and incidence model can be formulated
to allow simultaneous estimation of the prevalence
parameters θt, the compartment proportions ct and
the transition rates λt including λ
s,u
t , the incidence
rate, that is, the rate at which susceptible individ-
uals enter the infected state. The DAG in Figure 3
provides a schematic representation of this joint
model. The proportions ct+1 at time t+ 1 are de-
fined, through the ODEs, in terms of the rates λt
during the period [t, t+1) and the initial condition
of the system at t= 1. The prevalence parameters θt
and λt govern the prevalence and rate data, respec-
tively. Note that this DAG has the same structure
as that in Figure 1. Now the λt and c1 are the
basic parameters and the θt are functional parame-
ters.
Inference is conducted as described in Section 2.
The likelihood of the joint data is
L(c1,λ;y,z) =
T∏
t=1
Lt(c1;yt)Lt(λt;zt),
where Lt(λt;zt) is the likelihood contribution of the
demographic and behavioural data informing tran-
sition rates. Assuming independent vague priors for
λt and a Dirichlet(1,1,1,1) prior for the compart-
ment proportions at t = 1, c1, the joint posterior
distribution for c1 and λ, and therefore also of θ,
is obtained through MCMC implemented in Win-
BUGS. Note that the likelihood contribution of the
prevalence data, yt, depends on the ct, the ODEs’
solutions, which are derived numerically for the cur-
rent parameter values at each MCMC iteration us-
ing the Runge-Kutta algorithm in the WBDiff pack-
age in WinBUGS. Figure 4 shows posterior distribu-
tions resulting from the joint prevalence and inci-
dence model.
5. DISCUSSION
From a methodological point of view, this work
has responded formally to the need, perceived by
epidemiologists working in the HIV arena, to “tri-
angulate” all information: from multiple and imper-
fect sources and expert opinion on the epidemiolog-
ical interpretation of the data from these sources.
The approach is clearly appealing: it uses data fully,
minimising potential biases due to selection of infor-
mation; it typically leads to more precise estimates,
which are consistent with all information; and it ac-
counts for all sources of uncertainty, naturally re-
flected in the posterior distributions of parameters
and quantities of interest.
5.1 Why Bayesian?
In principle, evidence synthesis does not need to
be carried out in a Bayesian framework; see, for in-
stance, Eddy, Hasselblad and Shachter (1992) and
much of the meta-analytical work referenced in Sut-
ton et al. (2000). Indeed, work exists to estimate
HIV prevalence in a single risk group by synthesising
three data sources in a classical approach, account-
ing for missing data (Walker et al. (2011)). How-
ever, the unprecedented multiplicity of data sources,
risk groups and indirect information involved in the
work described here requires a Bayesian approach,
with clear benefits over classical, likelihood-based
alternatives. The main advantage is the ability to
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Fig. 4. Density strip plots of posterior distributions of incidence and diagnosis rates in MSM (darker colour corresponds to
higher density and horizontal black line denotes the posterior median), 2002–2008.
(i) explicitly introduce and (ii) formally quantify
expert judgements. The hierarchical model intro-
duced in Section 3.2 to tackle data sparseness of-
fers such an example: only through reasonably cho-
sen informative priors on the standard deviation
hyperparameters has it been possible to overcome
identifiability problems due to lack of information
(see sensitivity analyses in Presanis (2010)). Sec-
ond, a Bayesian model can be easily extended to
include auxiliary “bias” parameters to quantify lack
of validity and relevance of data items for the esti-
mation for any specific parameter. Expert epidemi-
ological information on the direction and magni-
tude of such biases is naturally accommodated in a
Bayesian setup through carefully chosen priors (see
Section 3.2 and references therein). It is not imme-
diately obvious how a classical modelling approach
would accommodate such information. Computa-
tional convenience represents a further advantage of
a Bayesian approach. As the posterior distribution is
estimated through simulation, it is straightforward
to obtain inferences on any functional parameter of
interest. The likelihood function of even a moder-
ately sized evidence network is unlikely to be suf-
ficiently tractable to allow comparably streamlined
inference.
5.2 Impact on the Real World
Since 2005 our “multi-parameter” evidence syn-
thesis has been the approach adopted to produce the
official estimates of the magnitude of the HIV prob-
lem in the UK, in particular, the undiagnosed com-
ponent, underlying current testing recommenda-
tions (http://www.hpa.org.uk/web/HPAweb&Page&
HPAwebAutoListName/Page/1201094588821). In
2011, estimated trends on the prevalence of undi-
agnosed infection and incidence in MSM informed
the work of the House of Lords Select Committee
on HIV/AIDS in the UK (http://www.publications.
parliament.uk/pa/ld201012/ldselect/ldaids/188/188.
pdf). Recently, dissemination of the method has also
attracted the interest of international public health
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organisations. Funded by the World Health Organi-
zation as part of an ongoing critical review of current
methods for HIV prevalence estimation in concen-
trated epidemics (Ghys et al. (2008)), the prevalence
model has been adapted to estimate HIV burden
in the Netherlands for the year 2007 (Conti et al.
(2011)). In comparison to other direct-type meth-
ods, the evidence synthesis approach was found to
be the most flexible and statistically sound (van
Veen et al. (2011)).
5.3 Current Challenges
The model building and criticism processes in this
work have led to a critical understanding of the
strengths and weaknesses of the various sources of
HIV information available in the UK, often challeng-
ing common interpretation of the data. Extensive
sensitivity analyses have been carried out for prior
and structural assumptions, to the sampling distri-
butions employed, as well as to the data sources
included (Goubar et al. (2008), Presanis et al. 2008,
2011, Presanis (2010)). Moreover, routine annual
application of the model has led to continual model
development, responding to changes in surveillance,
the availability of new data sources, and ongoing
model criticism in the cycle recommended by Box
(1980) and O’Hagan (2003), amongst others. Some
of the development required and in progress includes
addressing issues of missing data, using ideas as in
Walker et al. (2011) and a comprehensive model
of the process of diagnosis in STI clinics based
on a new surveillance system (http://www.hpa.org.
uk/Topics/InfectiousDiseases/InfectionsAZ/HIV/
OverallHIVPrevalence/).
More generally, model criticism is essential in an
evidence synthesis approach. As data come from
multiple sources depending on shared parameters,
it becomes crucial to understand and communicate
which sources (including priors) drive conclusions
and whether the various items of evidence result
in consistent or conflicting inference. Efforts clearly
need to be focussed on the development of trans-
parent methods for model assessment and criticism,
given that evidence synthesis approaches are being
increasingly employed in different areas of science.
In the same spirit, an important step toward im-
proved communication and dissemination of Bayes-
ian evidence synthesis would be the availability of
a user-friendly computing environment, facilitating
access and implementation of the methodology to
nonexperts. van Veen et al. (2011) also identified the
lack of such a modelling interface as a restriction to
the more widespread adoption of our approach.
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